CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

The Lustgarten Foundation Announces New Pancreatic Cancer Research Funding Totaling $22.8 Million In Fiscal Year 2026

Positive
AI Analysis

Summary

The Lustgarten Foundation announced $22.8 million in new pancreatic cancer research funding for fiscal year 2026, representing an $8.6 million increase year-over-year.

Importance:2/10
Sentiment:
0.60
pancreatic cancerresearch fundingLustgarten Foundation
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 20, 2026 6:20 PM

Read Original